justicedao/ipfs_state_laws huggingface dataset:
410-120-1940 Interest Payments on Overdue Claims (1) Upon request by the provider, the Division will pay interest on an overdue claim: (a) A claim is considered “overdue” if Division does not make payment within 45 days of receipt of a valid claim; (b) The interest rate shall be the usual rate charged by the provider to the provider’s clientele, but not more than 2/3 percent per month or eight percent per year. (2) When billing Division for interest on an overdue valid claim the provider must furnish the following information in writing: (a) Name of the service and the location the service was provided; (b) The name of the client who received the service; (c) Client ID Number; (d) Date of service; (e) Date of initial valid billing of the Division; (f) Amount of billing on initial valid claim; (g) Division Internal Control Number (ICN) of claim; (h) Certification, signed by the provider or the provider’s authorized agent, that the amount claimed does not exceed the usual overdue account charges assessed by the provider to the provider’s clientele. Statutory/Other Authority: ORS 413.042 Statutes/Other Implemented: ORS 414.025 & 414.065 History: DMAP 37-2023, minor correction filed 04/28/2023, effective 04/28/2023 OMAP 39-2005, f. 9-2-05, cert. ef. 10-1-05 OMAP 42-2002, f. & cert. ef. 10-1-02 OMAP 31-1999, f. & cert. ef. 10-1-99 HR 32-1993, f. & cert. ef. 11-1-93, Renumbered from 410-120-0360 HR 2-1990, f. 2-12-90, cert. ef. 3-1-90, Renumbered from 461-013-0185 AFS 24-1985, f. 4-24-85, ef. 6-1-85 AFS 52-1982, f. 5-28-82, ef. 6-30-82 AFS 47-1982, f. 4-30-82, ef. 5-1-82
410-120-1980 Requests for Information and Public Records (1) The Division of Medical Assistance Programs (Division) will make non-exempt public records available for inspection to persons making a public records request under ORS 192.410 to 192.500. (2) Division may charge a fee for copies of non-exempt public records to cover actual costs per OAR 943-003-0010. Statutory/Other Authority: ORS 413.042 Statutes/Other Implemented: ORS 192.410 - 192.505 History: DMAP 3-2007, f. & cert. ef. 6-1-07 OMAP 39-2005, f. 9-2-05, cert. ef. 10-1-05 HR 32-1993, f. & cert. ef. 11-1-93
410-121-0021 Organizations Authorized to Provide Pharmaceutical Prescription Services (1) Pharmacies, and Medicare certified independent rural health clinics providing urgent medical services for clients as defined in ORS 414.325(7) may provide drug prescription services for fee-for-service Division of Medical Assistance Programs (Division) clients and receive reimbursement from Division by complying with all the following requirements: (a) Comply with all applicable Federal and State statutes, regulations and rules; (b) Meet all current licensing and regulatory requirements; (c) Be enrolled as a pharmacy provider with Division; (d) Pharmacies must have a current National Association of the Board of Pharmacy (NABP) number to bill Division; (e) Medicare certified independent rural health clinics must have a pharmacist, physician, or nurse practitioner, licensed to dispense and bill drug prescriptions; and (f) Comply with Division pharmacy billing requirements. (2) Refer to OAR 410-120-1260 for enrollment details. Statutory/Other Authority: ORS 413.042 Statutes/Other Implemented: ORS 414.065 History: DMAP 16-2008, f. 6-13-08, cert. ef. 7-1-08 OMAP 9-2005, f. 3-9-05, cert. ef. 4-1-05 OMAP 41-2004, f. 6-24-04 cert. ef. 7-1-04 OMAP 84-2003, f. 11-25-03 cert. ef. 12-1-03
410-121-0032 Supplemental Rebate Agreements (1) The Division of Medical Assistance Programs (Division) has both a, Centers for Medicare and Medicaid Services (CMS) approved Supplemental Rebate Agreement and a (CMS) approved Value based Agreement. These templates and instructions are available on the Oregon Health Authority’s (Authority) web site at: www.oregon.gov/OHA/healthplan/pages/pharmacy-policy.aspx (2) The Division negotiates Supplemental Rebate Agreements for specific drug products through the Sovereign States Drug Consortium (SSDC) multi-state pool and pharmaceutical manufacturers. Negotiations are confidential, and shall not be disclosed, except in connection with an agreement/contract or as may be required by law. Confidentiality is required of any third party involved in administration of the agreement/contract. (3) Manufacturers may submit supplemental rebate offers or value base offers for consideration to include their drug(s) on the Practitioner’s-Managed Prescription Drug Plan (PMPDP) Preferred Drug List (PDL), OAR 410-121-0030 after gaining access to the SSDC secure web-based offer entry system. (4) Manufacturers must abide by requirements of the SSDC. (5) The Practitioner-Managed Prescription Drug List (PMPDP) also called the Preferred Drug List (PDL) consist of drugs after the Food and Drug Administration (FDA) has determined to be safe and effective and reimbursable as determined by the Centers for Medicaid and Medicare Services (CMS), and evaluated using an evidence-based review process by the Pharmacy & Therapeutics Committee (P&T) . If pharmaceutical manufacturers enter into supplemental rebate agreements with the SSDC, the Authority may include that drug on the PDL. (6) Acceptance of the offer: (a) The Division may accept an offer through the SSDC; (b) The SSDC shall notify manufacturers of the status of their offer(s). (c) Supplemental Agreements shall be executed after signed by all parties, approved by CMS if required, and added to the PMPDP Preferred Drug List by the Administrative rule process. (d) The Division may contract for the functions of tracking utilization, invoicing, and dispute resolution for supplemental rebate products. Statutory/Other Authority: ORS 414.065, ORS 413.042, ORS 409.025, 409.040 & 409.110 Statutes/Other Implemented: ORS 414.065 History: DMAP 96-2023, amend filed 12/22/2023, effective 01/01/2024 DMAP 40-2018, minor correction filed 05/25/2018, effective 05/25/2018 DMAP 35-2018, minor correction filed 05/25/2018, effective 05/25/2018 DMAP 44-2011, f. 12-21-11, cert. ef. 1-1-12 DMAP 39-2009, f. 12-15-09, cert. ef. 1-1-10 DMAP 14-2009, f. 6-12-09, cert. ef. 7-1-09 DMAP 36-2008, f. 12-11-08, cert. ef. 1-1-09 DMAP 16-2008, f. 6-13-08, cert. ef. 7-1-08 OMAP 97-2004, f. 12-30-04, cert. ef. 1-1-05
410-121-0033 Polypharmacy Profiling (1) The Division of Medical Assistance Programs may impose prescription drug payment limitations on clients with more than 15 unique fee-for-service drug prescriptions in a six-month period. (2) The Division will review the client’s drug therapy in coordination with the client's prescribing practitioner to evaluate for appropriate drug therapy. (3) Appropriate drug therapy criteria will include, but is not limited to, the following: (a) Overuse of selected drug classes; (b) Under-use of generic drugs; (c) Therapeutic drug duplication; (d) Drug to disease interactions; (e) Drug to drug interactions; (f) Inappropriate drug dosage; (g) Drug selection for age; (h) Duration of treatment; (i) Clinical abuse or misuse. (4) The Division Medical Director in conjunction with the Drug Use Review/Pharmacy & Therapeutics Committee will make final determinations on imposed drug prescription payment limitations relating to this policy. Statutory/Other Authority: ORS 413.042 Statutes/Other Implemented: ORS 414.065 History: DMAP 61-2012, f. 12-27-12, cert. ef. 1-1-13 DMAP 42-2012(Temp), f. & cert. ef. 9-12-12 thru 3-10-13 DMAP 12-2012(Temp), f. & cert. ef. 3-16-12 thru 9-11-12 DMAP 27-2011(Temp), f. & cert. ef. 9-30-11 thru 3-15-12 OMAP 1-2004, f. 1-23-04, cert. ef. 2-1-04
410-121-0060 How to Get Prior Authorization for Drugs (1) A prescriber electing to order a drug requiring PA may have any licensed medical personnel in their office request the PA. The PA request may be transmitted to the Oregon Pharmacy Help Desk by any of the following methods: (a) Call the Oregon Pharmacy Help Desk (b) FAX the request form shown in the Pharmaceutical Services Supplemental Information on the Oregon Health Authority’s website to the Oregon Pharmacy Help Desk (c) Transmit the request electronically via the secure MMIS web portal. (2) The status of a PA request received from prescribers or their licensed medical personnel will be reported on the secure MMIS web portal, or by calling the Automated Voice Recognition (AVR) System, within 24 hours of receipt by the Oregon Pharmacy Help Desk (3) PA approval: (a) It is the pharmacy personnel’s responsibility to check whether the drugs are covered, whether the client is eligible, and to note restrictions such as date ranges and quantities before dispensing any medications that require PA. (b) The pharmacy personnel must also check whether the client’s prescribed medications are covered by a managed care plan because an enrollment may have taken place after PA was received. If the client is enrolled in a managed care plan and the pharmacy receiving the PA is not a participating pharmacy provider in the managed care plan’s network, the pharmacy must inform the client that it is not a participating provider in the managed care plan’s network and must also recommend that the client contact his or her managed care plan for a list of pharmacies participating in its network. (c) After a PA request is approved, the patient will be able to fill the prescription at any Medicaid pharmacy provider, if consistent with all other applicable administrative rules. (4) If the PA request has been denied, notification to client and prescriber will occur in accordance with OHP General Rules 410-120-1860. (5) Emergency Need: The Pharmacist may request an emergent or urgent dispensing from the Pharmacy Benefits Manager (PBM) when the client is eligible for covered fee-for-service drug prescriptions. (a) Clients who do not have a PA pending may receive an emergency dispensing for a 96-hour supply. (b) Clients who do have a PA pending may receive an emergency dispensing up to a seven-day supply. Statutory/Other Authority: ORS 413.042 & 414.065 Statutes/Other Implemented: ORS 414.065 History: DMAP 128-2024, minor correction filed 10/14/2024, effective 10/14/2024 DMAP 39-2009, f. 12-15-09, cert. ef. 1-1-10 DMAP 36-2008, f. 12-11-08, cert. ef. 1-1-09 DMAP 34-2008, f. 11-26-08, cert. ef. 12-1-08 OMAP 16-2006, f. 6-12-06, cert. ef. 7-1-06 OMAP 18-2004, f. 3-15-04 cert. ef. 4-1-04 OMAP 20-2003, f. 3-26-03, cert. ef. 4-1-03 OMAP 29-2000, f. 9-29-00, cert. ef. 10-1-00 OMAP 1-1999, f. & cert. ef. 2-1-99 HR 2-1995, f. & cert. ef. 2-1-95 HR 20-1994, f. 4-29-94, cert. ef. 5-1-94 HR 29-1990, f. 8-31-90, cert. ef. 9-1-90, Renumbered from 461-016-0180 AFS 56-1989, f. 9-28-89, cert. ef. 10-1-89
410-121-0061 Durable Medical Equipment, Medical Supplies, and Medical Surgical Services (Physician Administered Drugs) Follow the guidelines in the Durable Medical Equipment and Medical Supplies (OAR 410 Division 122), Home Enteral/Parenteral Nutrition and IV Services (OAR chapter 410, division 148), and Medical Surgical Services (OAR chapter 410, division 130) administrative rules and supplemental information for billing and prior authorization of these medical supplies and services. This information is available on the Oregon Health Authority’s web site. Statutory/Other Authority: ORS 413.042 Statutes/Other Implemented: ORS 414.065 History: DMAP 44-2011, f. 12-21-11, cert. ef. 1-1-12 OMAP 18-2004, f. 3-15-04 cert. ef. 4-1-04 OMAP 40-2003, f. 5-27-03, cert. ef. 6-1-03 OMAP 1-1999, f. & cert. ef. 2-1-99 HR 20-1994, f. 4-29-94, cert. ef. 5-1-94 HR 26-1991, f. & cert. ef. 7-1-91
410-121-0143 Client Confidentiality Pharmacists are responsible for maintaining the confidentiality of client information in compliance with HIPAA standards. Facilities shall provide adequate privacy for patient consultations. Statutory/Other Authority: ORS 413.042 Statutes/Other Implemented: ORS 414.065 History: OMAP 18-2004, f. 3-15-04 cert. ef. 4-1-04 HR 16-1992, f. & cert. ef. 7-1-92
410-121-0145 Prescription Requirements (1) Division of Medical Assistance Programs (Division) will make payment for covered drugs supplied on drug order or prescription of a licensed practitioner and dispensed by a pharmacist. Dispensings include new prescriptions, refills of existing prescriptions, and over-the-counter (OTC) medications. (2) Each drug order or prescription filled for a Division client must: (a) Be retained in the pharmacy's file at the pharmacy’s place of business; and, (b) All drug orders or prescriptions must comply with the Oregon State Board of Pharmacy rules and regulations as listed in OAR 855 Division 041. Statutory/Other Authority: ORS 413.042 & 414.065 Statutes/Other Implemented: ORS 414.065 History: DMAP 71-2025, amend filed 09/25/2025, effective 10/01/2025 DMAP 2-2010, f. 2-1-10, cert. ef. 2-5-10 DMAP 9-2008, f. 3-31-08, cert. ef. 4-1-08 DMAP 4-2007, f. 6-14-07, cert. ef. 7-1-07 OMAP 18-2004, f. 3-15-04 cert. ef. 4-1-04 OMAP 1-1999, f. & cert. ef. 2-1-99 HR 25-1994, f. & cert. ef. 7-1-94 HR 29-1990, f. 8-31-90, cert. ef. 9-1-90, Renumbered from 461-016-0200 AFS 56-1989, f. 9-28-89, cert. ef. 10-1-89, Renumbered from 461-016-0020 AFS 4-1989, f. 1-31-89, cert. ef. 2-1-89 AFS 53-1985, f. 9-20-85, ef. 10-1-85 AFS 52-1982, f. 5-28-82, ef. 6-30-82 AFS 44-1982, f. 4-30-82, ef. 5-1-82 PWC 869, f. 12-30-77, ef. 1-1-78 PWC 831, f. 2-18-77, ef. 3-1-77 PWC 818(Temp), f. 10-22-76, ef. 11-1-76
410-121-0148 Dispensing in a Nursing Facility or Community Based Care Living Facility A pharmacy serving Division of Medical Assistance Program’s (Division) clients in a nursing facility or a Community Based Care Living Facility must dispense medication in a manner consistent with Board of Pharmacy rules as set out in OAR 855-041. (1) For the purposes of this rule, “Long term care facility” includes skilled nursing facilities and intermediate care facilities consistent with the definitions in ORS 443.400 to 443.455. (2) An intermediate care facility is a facility providing regular health related care and services to individuals at a level above room and board, but less than hospital or skilled nursing levels ORS 442.015. Statutory/Other Authority: 404.110, 413.042 & 414.065 Statutes/Other Implemented: ORS 414.065 History: DMAP 26-2007, f. 12-11-07, cert. ef. 1-1-08 OMAP 18-2004, f. 3-15-04, cert. ef. 4-1-04 OMAP 1-1999, f. & cert. ef. 2-1-99 HR 20-1994, f. 4-29-94, cert. ef. 5-1-94 HR 29-1990, f. 8-31-90, cert. ef. 9-1-90, Renumbered from 461-016-0230 AFS 56-1989, f. 9-28-89, cert. ef. 10-1-89, Renumbered from 461-016-0070 AFS 52-1986, f. & cert. ef. 7-2-86 AFS 16-1985, f. 3-26-85, cert. ef. 5-1-85 AFS 58-1983, f. 11-30-83, cert. ef. 1-1-84 AFS 99-1982, f. 10-25-82, cert. ef. 11-1-82 AFS 83-1982(Temp), f. & cert. ef. 9-2-82 AFS 52-1982, f. 5-28-82, cert. ef. 6-30-82 AFS 44-1982, f. 4-30-82, cert. ef. 5-1-82 PWC 869, f. 12-30-77, cert. ef. 1-1-78 PWC 831, f. 2-18-77, cert. ef. 3-1-77 PWC 818(Temp), f. 10-22-76, cert. ef. 11-1-76
410-121-0190 Medication Therapy Management Services and Clozapine Therapy Monitoring (1) Clozapine monitoring protocol requires enhanced record keeping and reporting to the drug manufacturer’s registry in order to dispense the medication. Dispensing pharmacy must meet all drug manufacturers requirements including data reporting. (2) Clozapine monitoring includes documentation of client’s diagnosis, dosage, dosage changes, appropriate laboratory reports (e.g. white blood cell counts), evaluation intervals, and submission of appropriate information to drug manufacturer to allow dispensing of medication; (3) Clozapine monitoring is to be billed using appropriate Medication Therapy Management Services (MTMS) Current Procedural Terminology (CPT) code with the modifier TC appended. This is limited to no more than 5 units in 30 day time period per client, including the 30 day period from the date of discontinuation of clozapine therapy; (4) Clozapine monitoring must be billed by a pharmacy; (5) MTMS rendered outside of clozapine management must be performed by a licensed pharmacist and must be billed to appropriately reflect the performing provider. These encounters must be billed using the appropriate MTMS CPT code without the TC modifier. Statutory/Other Authority: ORS 413.042 & 414.065 Statutes/Other Implemented: ORS 414.065 History: DMAP 26-2013, f. & cert. ef. 6-25-13 DMAP 59-2012(Temp), f. 12-27-12, cert. ef. 12-28-12 thru 6-25-13 DMAP 44-2011, f. 12-21-11, cert. ef. 1-1-12 OMAP 61-2005, f. 11-29-05, cert. ef. 12-1-05 OMAP 9-2005, f. 3-9-05, cert. ef. 4-1-05 OMAP 18-2004, f. 3-15-04 cert. ef. 4-1-04 OMAP 57-2003, f. 9-5-03, cert. ef. 10-1-03 OMAP 40-2003, f. 5-27-03, cert. ef. 6-1-03 OMAP 20-2003, f. 3-26-03, cert. ef. 4-1-03 OMAP 45-2002, f. & cert. ef. 10-1-02 OMAP 31-2001, f. 9-24-01, cert. ef. 10-1-01 OMAP 17-2001, f. 3-30-01, cert. ef. 4-1-01 OMAP 1-1999, f. & cert. ef. 2-1-99 HR 6-1995, f. 3-31-95, cert. ef. 4-1-95 HR 20-1994, f. 4-29-94, cert. ef. 5-1-94
410-121-0200 Billing Forms Guidelines for using the Prescription Drug Invoice 1.2 Universal Claim Form. (1) When a paper claim form is needed, this form is used to bill for all pharmacy services, home blood glucose monitors, and related diabetic supplies. These services must be billed with a National Drug Code (NDC). (2) The provider may bill on the form when a valid Medical Care Identification has been presented (Refer to OAR 410-120-1140 Verification of Eligibility). (3) All completed 1.2 Universal Claim Forms must be mailed to the Health Systems Division (Division). (4) All other durable medical equipment and certain Enteral/Parenteral Nutrition and IV Services must be billed on the CMS-1500, using the billing instructions found in the Division’s Durable Medical Equipment and Medical Supplies administrative rules (division 122) and Supplemental Information, and the Division’s Home Enteral/Parenteral Nutrition and IV Services Administrative rules (division 148) and Supplemental Information. These services are billed with HCPCS procedure codes. NOTE: Publications referenced are available from the agency. Statutory/Other Authority: ORS 413.042 & 414.065 Statutes/Other Implemented: ORS 414.065 History: DMAP 11-2018, amend filed 03/02/2018, effective 03/02/2018 DMAP 14-2011, f. 6-29-11, cert. ef. 7-1-11 DMAP 34-2008, f. 11-26-08, cert. ef. 12-1-08 OMAP 18-2004, f. 3-15-04 cert. ef. 4-1-04 OMAP 40-2003, f. 5-27-03, cert. ef. 6-1-03 OMAP 20-2003, f. 3-26-03, cert. ef. 4-1-03 HR 20-1994, f. 4-29-94, cert. ef. 5-1-94 HR 29-1990, f. 8-31-90, cert. ef. 9-1-90
410-121-0220 Instructions for Completion of the Prescription Drug Invoice (1) The 1.2 Universal Claim Form is the required billing form for pharmacies billing on a paper claim. Use the standard instructions for completion of the 1.2 Universal Claim Form. (2) Enter all applicable information for billing of prescription drug claims for clients on the Oregon Health Plan. Statutory/Other Authority: ORS 413.042, 414.034 & 414.065 Statutes/Other Implemented: ORS 414.065 History: DMAP 11-2018, amend filed 03/02/2018, effective 03/02/2018 OMAP 40-2003, f. 5-27-03, cert. ef. 6-1-03 OMAP 1-1999, f. & cert. ef. 2-1-99 HR 23-1995, f. 12-29-95, cert. ef. 1-1-96 HR 2-1995, f. & cert. ef. 2-1-95 HR 20-1994, f. 4-29-94, cert. ef. 5-1-94 HR 14-1993, f. & cert. ef. 7-2-93 HR 29-1990, f. 8-31-90, cert. ef. 9-1-90, Renumbered from 461-016-0280 AFS 56-1989, f. 9-28-89, cert. ef. 10-1-89
410-121-0280 Billing Quantities, Metric Quantities and Package Sizes (1) Use the actual metric quantity dispensed when billing (up to four decimal places). (2) Use the following units when billing products: (a) Solid substances (e.g., powders, creams, ointments, etc.), bill per Gram; (b) Solid substances that are reconstituted with a liquid (e.g., dry powder ampules and vials) such as antibiotic vials or piggybacks must be billed in metric quantity of one each; (c) Tablets, capsules, suppositories, lozenges, packets; bill per each unit. Oral contraceptives are to be billed per each tablet; (d) Injectables that are prepackaged syringe — (e.g., tubex, carpujects), bill per ml.; (e) Prepackaged medications and unit doses must be billed per unit (tablet or capsule). Unit dose liquids are to be billed by ml.; (f) Fractional units: Bill exact metric decimal quantities dispensed. Statutory/Other Authority: ORS 413.042, 414.034 & 414.065 Statutes/Other Implemented: ORS 414.065 History: OMAP 1-1999, f. & cert. ef. 2-1-99 HR 20-1994, f. 4-29-94, cert. ef. 5-1-94 HR 29-1990, f. 8-31-90, cert. ef. 9-1-90, Renumbered from 461-016-0320 AFS 56-1989, f. 9-28-89, cert. ef. 10-1-89
410-121-0420 DESI Less-Than-Effective Drug List (1) An October 23, 1981 ruling by District of Columbia Federal Court directed the Department of Health and Human Services to stop reimbursement, effective October 30, 1981, under Medicaid and Medicare Part B for all DESI less-than-effective drugs which have reached the Federal Drug Administration Notice-of-Opportunity-for-Hearing stage. (2) In accordance with Section 1903(i)(5) of the Social Security Act, federal funds participation (FFP) is not available for drugs deemed Less Than Effective (LTE) or Identical, Related of Similar (IRS) drugs for which the Food and Drug Administration (FDA) issued a Notice of Opportunity for a Hearing (NOOH) for all labeled indications. These drugs are also termed Drug Efficacy Study Implementation (DESI) drugs. Division does not reimburse for drugs designated as less than effective or drugs identical, related, or similar to a DESI drug. (3) A current list of DESI LTE/IRS drugs is available at https://www.medicaid.gov/medicaid/prescription-drugs/medicaid-drug-rebate-program/medicaid-drug-rebate-program-data/index.html. DESI drugs are identified by Covered outpatient Drug (COD) Status of 5 or 6. (4) The US Food & Drug Administration (FDA) has the responsibility of determining the DESI status of a drug product. Statutory/Other Authority: ORS 413.042 & 414.325 Statutes/Other Implemented: ORS 414.065 History: DMAP 96-2022, amend filed 12/28/2022, effective 01/01/2023 DMAP 38-2018, minor correction filed 05/25/2018, effective 05/25/2018 DMAP 39-2009, f. 12-15-09, cert. ef. 1-1-10 OMAP 18-2004, f. 3-15-04 cert. ef. 4-1-04 OMAP 29-2000, f. 9-29-00, cert. ef. 10-1-00 OMAP 1-1999, f. & cert. ef. 2-1-99 HR 20-1994, f. 4-29-94, cert. ef. 5-1-94 HR 20-1991, f. & cert. ef. 4-16-91 HR 29-1990, f. 8-31-90, cert. ef. 9-1-90, Renumbered from 461-016-0390 HR 17-1990(Temp), f. 6-29-90, cert. ef. 7-1-90 AFS 79-1989, f. & cert. ef. 12-21-89 AFS 64-1989(Temp), f. 10-24-89, cert. ef. 11-15-89 AFS 56-1989, f. 9-28-89, cert. ef. 10-1-89
410-121-0625 Items Covered in the All-Inclusive Rate for Nursing Facilities (1) The all-inclusive rate for nursing facilities includes but is not limited to various drug products and OTC items. Division requires that nursing facilities be billed for these items. (2) The all-inclusive list is available for downloading in the Division of Medical Assistance Programs Web page on the Oregon Health Authority’s website. Statutory/Other Authority: ORS 413.042 & 414.065 Statutes/Other Implemented: ORS 414.065 History: DMAP 36-2008, f. 12-11-08, cert. ef. 1-1-09 OMAP 18-2004, f. 3-15-04 cert. ef. 4-1-04 OMAP 31-2001, f. 9-24-01, cert. ef. 10-1-01, Renumbered from 410-121-0920 OMAP 1-1999, f. & cert. ef. 2-1-99 HR 20-1994, f. 4-29-94, cert. ef. 5-1-94 HR 26-1990, f. 8-31-90, cert. ef. 9-1-90